This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
By not including a fix to the 3.37% cut to the Medicare Physician Fee Schedule in the most recent continuing resolution, practices around the country are left in a state of uncertainty for their own futures, as well as patient access to care,” said American College of Cardiology President B.
By integrating a real-time frailty risk score into the electronic medical record (EMR), presenting stroke severity and other variables, we can proactively identify who will benefit from immediate surgery and who may need pre-habilitating before surgery to achieve better outcomes.
Medicare beneficiaries who underwent CABG from 2001 to 2019. They noted that because their analysis was focused on the Medicare population, the cohort was limited to older patients. the data and outcomes from the STS Database specialty registries provide true national benchmarks for clinical outcomes of cardiothoracic surgery.
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BACKGROUND:Although Medicare Advantage (MA) plans provide coverage to >50% of Medicare beneficiaries, it is unclear whether MA claims can be used similarly to Medicare Fee-For-Service (FFS) claims for clinical outcomes assessment.
Less than two weeks after Novo Nordisk’s weight-loss drug Wegovy gained expanded FDA approval for cardiovascular event risk reduction, CMS issued a new Medicare Part D guidance that allows coverage of obesity drugs for senior patients with “an additional medically accepted indication”… like cardiovascular disease.
Differenceindifferences analyses were used to compare differences in outcomes before (20142015) and after (20182019; 2year CR period=20162017) the CR period between participants and nonparticipants.ResultsWe identified 57 668 CReligible beneficiaries after matching, with equal numbers of participants and nonparticipants.
With this new funding, Cleerly will continue to scale its commercial growth and clinical evidence generation, helping health care professionals improve outcomes for patients across the coronary care pathway. We’re proud to be a part of Cleerly’s journey.
The Micra AV Coverage with Evidence Development (CED) study is a novel analysis of utilization and outcomes associated with Micra AV leadless pacing among US Medicare patients.
Introduction:Stroke prevalence is highest in adults ages>65 years, the majority of whom are Medicare beneficiaries. Fee-for-Service (FFS) Medicare incentivizes utilization by paying for each service. Medicare Advantage (MA) uses capitated payments to reduce overutilization. Another showed lower mean mortality and 0.5%
Yasser Sammour, MD, MScpresented "Long-Term Hemodynamic Performance and Clinical Outcomes in Small and Large Aortic Annuli Patients with Severe Aortic Stenosis."This The association of BVD with clinical outcomes (unadjusted for covariates) was evaluated by small and large annuli (CT annular diameter 23 vs >23 mm).
Stent Durability and Patency at 2 years A Prospective Study of the Next Generation AVENTUS Thrombectomy System: Advancing Thrombectomy and Autologous Blood Reinfusion for Pulmonary Embolism Incidence and Gender-Based Comparison of Prosthesis-Patient Mismatch (PPM) in patients undergoing transcatheter aortic valve implantation (TAVI) Percutaneous (..)
The researchers found that Medicare patients undergoing esophagectomy for cancer exhibit identifiable predictors for long-term survival and readmission. These findings suggest opportunities to enhance clinical practice and improve outcomes for Medicare patients undergoing esophagectomy for cancer.
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Background:Traditional cardiac rehabilitation (CR) improves cardiovascular outcomes and reduces mortality, but less is known about the relative benefit of intensive CR (ICR) which incorporates greater lifestyle education through 72 sessions (versus 36 in CR).
However, the association of socioeconomic vulnerability and outcomes after hospitalization is uncertain.Methods and ResultsAmerican Heart Association COVID19 Cardiovascular Disease Registry hospitalizations between March 1, 2020, and June 30, 2022, linked with Medicare feeforservice claims, were analyzed.
vii Similarly, recent increases in Medicare reimbursement rates for CCTA are a positive step towards making this technology more accessible. This innovative technology maximizes operational efficiency, enhances staff expertise, and delivers better patient outcomes, making it a wise long-term investment. 2012) 380:2095128. link] iv IMV.2023
The CardiAMP cell therapy trials for the indications of both chronic myocardial ischemia and ischemic heart failure are covered by the Center for Medicare and Medicaid for both treatment and control procedures. CAUTION - Limited by United States law to investigational use.
Methods:We analyzed data on Medicare fee-for-service beneficiaries aged ≥65 years hospitalized with AIS from April 1, 2020, to December 31, 2021. Results:Among 249299 Medicare FFS beneficiaries with AIS, there were 57814 (23.2%) with low, 88565 (35.5%) moderate, and 102920 (41.3%) high SVI. 0.66, high 0.67-1.0).Results:Among
Publication date: Available online 22 October 2024 Source: The American Journal of Cardiology Author(s): Nathan W. Kong, Joseph M. Kim, Anna K. Krawisz, Patrick Heindel, Archana Tale, Yang Song, Jeffrey L. Weinstein, Mohamad A. Hussain, Eric A.
This cross-sectional study examines outcomes for patients hospitalized with heart failure to compare changes in the quality and outcomes of care according to hospital participation in the Medicare Bundled Payments for Care Improvement program.
Utilization trends were stratified by region, urbanicity, distressed communities index, community versus academic center, Medicare versus dual enrollment status, indication, urgency, and presence of dissection with malperfusion.
CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. Getty Images milla1cf Wed, 03/13/2024 - 16:49 March 13, 2024 — BioCardia, Inc. , Getty Images milla1cf Wed, 03/13/2024 - 16:49 March 13, 2024 — BioCardia, Inc. ,
CVD is especially prevalent in the Medicare-aged population, affecting more than 75 percent of those aged 60-79 and more than 90 percent of those aged 80 and over. About the Study The study evaluated engagement and clinical outcomes among age 65+ participants of an mHealth app-based CV risk self-management program.
This launch coincides with the receipt of pass-through status by the CMS, effectiveApril 1, securing a drug-specific Healthcare Common Procedure Coding System (HCPCS) billing code and coverage for traditional Medicare beneficiaries.
Methods:Data were retrieved from a CMS Qualified Entity housing healthcare utilization data for ≥80% of the Texas state population (100% of Medicare Fee-for-Service). Analytical sample included all Medicare enrollees with a primary discharge diagnosis (AIS or ICH) from 2016 to 2020. and 82.3% (Panel D).Conclusion:Post
Recent shifts in third-party payer reimbursement, led by the Centers for Medicare and Medicaid , have resulted in continued trends of minimally invasive cardiac procedures on stable patients increasingly being performed outside of a hospital setting.
Objective Implantable loop recorders (ILRs) are increasingly used for long-term rhythm monitoring after ischaemic and cryptogenic stroke, with the goal of detecting atrial fibrillation (AF) and subsequent initiation of oral anticoagulation to reduce risk of adverse clinical outcomes.
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BACKGROUND:Differences in the quality of hospitals where Black and White patients receive coronary artery bypass grafting (CABG) surgery have been documented.
Early results from the Micra AV CED study showed reductions in short-term complications associated with the Micra AV leadless pacemaker among US Medicare patients.
Findings presented in the NEJM support acoramidis as an effective and safe treatment option for patients with ATTR-CM and reinforce the hypothesis that greater stabilization of TTR may be associated with improved clinical outcomes. Medicare population. in the treatment arm of ATTRibute-CM into context, recent data from the U.S.
To improve outcomes and be in compliance with new regulations, it's crucial to better identify and address these issues during the recovery period. Stroke recovery is a challenging process that extends for months after hospital discharge. This missing puzzle piece matters now more than ever.
Secondary objectives evaluated all-cause mortality and adverse events following amputation.RESULTS:Of 33 036 total Medicare beneficiaries undergoing major amputation, 7885 (23.9%) were due to chronic limb-threatening ischemia; of these, 4988 (63.3%) received low-intensity and 2897 (36.7%) received high-intensity vascular care.
Guidelines recommend permanent pacemaker (PPM) implantation in patients with sinus node dysfunction (SND) to improve quality of life. Patients with heart failure with preserved ejection fraction (HFpEF) have many comorbidities including SND, but the optimal treatment approach for HFpEF with SND is uncertain.
"Our next generation RMS represents a leap forward over existing resorbable technology, incorporating technical innovations intended to address physicians' needs and optimize outcomes for patients suffering from CLTI.” For more information: www.biotronik.com References: 1 Kwong M.,
a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced the enrollment of the first patients in the company's IDE pivotal trial. These patients have very poor outcomes in terms of death and rehospitalization and therefore new therapy options are critically needed," stated Dr. Chehab.
10 , 11 , 12 , 13 As healthcare systems increasingly adopt value-based care models, extending monitoring beyond 48 hours can improve patient outcomes, reduce missed diagnoses, and help contain healthcare resource utilization. Long-term outcome of non-sustained ventricular tachycardia in structurally normal hearts. 2016;11(8).
A potentially serious drug interaction between diltiazem and apixaban or rivaroxaban has been reported in US Medicare patients taking these drugs together for atrial fibrillation. It was a retrospective cohort study which included US Medicare benefiaries aged 65 years or more with atrial fibrillation and follow up period was one year.
BackgroundStructural racism and rural/urban differences in stroke care affect care delivery and outcomes. Methods and ResultsIn this retrospective study using complete, deidentified inpatient Medicare data (20162019), we identified incident acute ischemic stroke admissions, demographics, and hospitallevel variables.
Introduction:This study evaluates the outcomes of a survivor-centric, navigator-driven, technology-enabled platform supporting survivors (SS) and care partners(CP) in post-stroke recovery. This mixed methods study utilizes focus group feedback, survey, app usage and patient-reported outcomes data.
We additionally compared end points across treatment arms using trial-adjudicated outcomes versus claims-based outcomes.RESULTS:Trial-adjudicated deaths were perfectly identified by claims.
We determined the utility of this score for predicting outcomes within one-year post-stroke/TIA.Methods:Analysis of adults with acute stroke/TIA (2012-2016) using linked data from the Australian Stroke Clinical Registry and administrative datasets (pharmaceutical, hospital, Medicare), as part of the PRECISE study.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content